Interestingly, both mechanisms involved in MC‐SeC treatment are known to be very efficacious in DMD patients: the extinction of the inflammatory response and the induction of expression of the dystrophin paralogue, utrophin, at the sarcolemma. This evidence concerns the gene DMD and Duchenne muscular dystrophy.